Bruno Taillan, MD; Jean-Gabriel Fuzibet, MD; Henri Vinti, MD; Alain Pesce, MD; Jill-Patrice Cassuto, MD; Pierre Dujardin, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: Aach (1) states that interferon is the most promising antiviral agent for treating patients with chronic type B viral hepatitis. For patients at risk for infection with human immunodeficiency virus (HIV), however, antiviral agents do not appear to be the optimal treatment of chronic type B viral hepatitis in those patients who may be simultaneously infected with hepatitis delta virus (2). We report eight cases of severe liver disease due to hepatitis B virus and concurrent hepatitis delta virus infections in patients treated with recombinant alpha-2-interferon, 5 MU three times a week for 6 months.
Taillan B, Fuzibet J, Vinti H, et al. Interferon and Delta Hepatitis. Ann Intern Med. 1988;109:760. doi: 10.7326/0003-4819-109-9-760_1
Download citation file:
Published: Ann Intern Med. 1988;109(9):760.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use